ATE332712T1 - Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe - Google Patents

Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Info

Publication number
ATE332712T1
ATE332712T1 AT00949769T AT00949769T ATE332712T1 AT E332712 T1 ATE332712 T1 AT E332712T1 AT 00949769 T AT00949769 T AT 00949769T AT 00949769 T AT00949769 T AT 00949769T AT E332712 T1 ATE332712 T1 AT E332712T1
Authority
AT
Austria
Prior art keywords
acid sequences
amino acid
nucleic acid
vaccines
anaemia virus
Prior art date
Application number
AT00949769T
Other languages
English (en)
Inventor
Steven Griffiths
Rachel Jane Ritchie
Joel Heppell
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE332712(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en
Priority claimed from GB0005848A external-priority patent/GB0005848D0/en
Priority claimed from GB0006674A external-priority patent/GB0006674D0/en
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE332712T1 publication Critical patent/ATE332712T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00949769T 1999-08-07 2000-08-07 Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe ATE332712T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9918588.6A GB9918588D0 (en) 1999-08-07 1999-08-07 Sequence
GB0005848A GB0005848D0 (en) 2000-03-11 2000-03-11 Sequence
GB0006674A GB0006674D0 (en) 2000-03-21 2000-03-21 Sequence

Publications (1)

Publication Number Publication Date
ATE332712T1 true ATE332712T1 (de) 2006-08-15

Family

ID=27255591

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949769T ATE332712T1 (de) 1999-08-07 2000-08-07 Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Country Status (12)

Country Link
US (7) US6919083B1 (de)
EP (2) EP1637614A3 (de)
AT (1) ATE332712T1 (de)
AU (1) AU6304100A (de)
CA (1) CA2378437C (de)
CY (1) CY1106175T1 (de)
DE (1) DE60029327T2 (de)
DK (2) DK1200132T4 (de)
ES (1) ES2267553T3 (de)
NO (1) NO328740B1 (de)
PT (1) PT1200132E (de)
WO (1) WO2001010469A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6304100A (en) 1999-08-07 2001-03-05 Novartis Ag Sequence
DE60017229D1 (de) * 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en) * 2000-09-28 2002-04-04 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
NZ578541A (en) 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
EP2482824B1 (de) 2009-10-02 2016-11-30 The Trustees of Columbia University in the City of New York Immunogene fisch-reoviren-zusammensetzungen
WO2013151662A2 (en) * 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus
WO2021123099A1 (en) * 2019-12-20 2021-06-24 Intervet International B.V. Reassorted isa virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
AU6304100A (en) 1999-08-07 2001-03-05 Novartis Ag Sequence
DE60017229D1 (de) 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
AU3539401A (en) 2000-01-07 2001-07-16 Akzo Nobel N.V. Vaccine for prevention and/or prophylaxis of infectious salmon anaemia in fish
WO2001066569A1 (en) 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en) 2000-09-28 2002-04-04 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus

Also Published As

Publication number Publication date
CA2378437C (en) 2014-01-21
NO20020573D0 (no) 2002-02-05
WO2001010469A2 (en) 2001-02-15
US20040146860A1 (en) 2004-07-29
PT1200132E (pt) 2006-11-30
NO328740B1 (no) 2010-05-03
EP1637614A3 (de) 2006-11-29
US7201910B2 (en) 2007-04-10
US20070041988A1 (en) 2007-02-22
US20100136038A1 (en) 2010-06-03
WO2001010469A3 (en) 2001-09-07
DE60029327T2 (de) 2007-07-05
CY1106175T1 (el) 2011-06-08
US7199108B2 (en) 2007-04-03
DK1200132T4 (da) 2010-04-19
DK200200167A (da) 2002-04-02
EP1200132B2 (de) 2010-02-17
US7128917B2 (en) 2006-10-31
DE60029327D1 (de) 2006-08-24
EP1200132A2 (de) 2002-05-02
DK1200132T3 (da) 2006-10-23
NO20020573L (no) 2002-04-05
CA2378437A1 (en) 2001-02-15
US20120071630A1 (en) 2012-03-22
EP1637614A2 (de) 2006-03-22
US20050164176A1 (en) 2005-07-28
US7998484B2 (en) 2011-08-16
EP1200132B1 (de) 2006-07-12
AU6304100A (en) 2001-03-05
US20050261227A1 (en) 2005-11-24
DK177298B1 (en) 2012-10-15
US6919083B1 (en) 2005-07-19
ES2267553T3 (es) 2007-03-16

Similar Documents

Publication Publication Date Title
GR3017770T3 (en) Feline infectious peritonitis virus diagnostic tools.
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
ATE318309T1 (de) Hcv-spezifische peptide, mittel dazu und ihre verwendung
ES2095852T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
NO20005608D0 (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DE60138703D1 (de) Transportpeptide abgeleitet von erns protein
NO20005217L (no) DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
DE60234811D1 (de) Verfahren und zusammensetzungen zur extraktion von proteinen aus zellen
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
DK1077999T3 (da) Moraxella catarrhalis-proteiner
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
ATE359293T1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
DE60120391D1 (de) Verwendung von hev-polypeptiden
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200132

Country of ref document: EP

RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties